Topic
drug
CDSCO Flags 103 Drugs as ‘Not of Standard Quality’; Labels Telma H Sample as Spurious
Of the 103 NSQ drug samples, 47 were identified by central drug laboratories, while 56 were tested at state drug…
Glenmark Pharma launches cardiovascular drug Empagliflozin in India
The drug has been launched under the brand names Glempa, Glempa –L and Glempa-M Glenmark Pharmaceuticals has launched Empagliflozin, a…
Sun Pharma’s $355 M Oncology Gamble Faces Market Challenges
Sun Pharmaceutical Industries’ $355 million acquisition of Checkpoint Therapeutics is a bold move, but analysts warn that it may not…
Biocon launches GLP -1, Liraglutide, in UK
The drug-device combination will be marketed in the UK under Liraglutide Biocon for diabetes (gVictoza) and Biolide for chronic weight…
Indian Pharma Under Scrutiny: A Genuine Concern or an Attempt to Undermine a Global Leader?
The Indian pharmaceutical industry—often hailed as the "pharmacy of the world"—finds itself at the centre of controversy. A new study…
Syngene to acquire multi-modal facility from Stelis Biopharma
To add 20,000 litres of installed biologics drug substance manufacturing capacity Syngene announced the acquisition of Unit 3 biologics manufacturing…
IIT Kanpur researchers paves way for new drug discovery
The discovery has led to the identification of a novel mechanism responsib e for regulating the function of GPCRs in…
GeneQuantum, WuXi XDC in partnership to empower innovative bioconjugates development
GeneQuantum will develop multiple ADC drugs through collaboration with Wuxi XDC GeneQuantum Healthcare (GQ), a global innovative biotechnology company dedicated…
Piramal Pharma Solutions launches ADCelerate
ADCelerate is a new, branded solution for antibody-drug conjugate drug development Piramal Pharma Solutions announced the launch of ADCelerate, a new, branded…